<p>*The discontinuous red lines indicate patients who maintained normal values throughout follow-up. The continuous black lines indicate patients who experienced a return to abnormal values at some time during the follow-up. Abbreviations: ETP, endogenous thrombin potential; F 1+2, prothrombin fragment 1+2; PAP, plasmin-antiplasmin.</p
<p>Baseline characteristics according to eGFR categories based on the last serum creatinine levels d...
Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concent...
<p>Dashed line indicates end of hemorrhage and beginning of reperfusion period. Data is depicted as ...
<p><b>Biomarkers:</b> N, sustained normalization of values throughout follow-up; nsn: non-sustained ...
<p>Abbreviations: IN<sub>0</sub>: tinzaparin injection before the start of the session at the inlet ...
<p>Median hemoglobin (A) and platelet counts (B) at baseline, at week 4, 8 and 12 and the nadir hemo...
<p>Plasma levels of TIMPs, CRP and I-FABP during follow-up of 3 patient groups.</p
<p>Percentage of patients with at least one dose reduction of RBV or PegIFN, at least one blood tran...
The serum levels of fucosylated haptoglobin at baseline and the end of treatment.</p
<p>Abbreviations : percentage of reticulocytes (Reti), lactate deshydrogenase (LDH), leukocytes (Leu...
<p>Thrombin generation analysis (1 pM TF) of plasma collected from 104 ACS and 42 non-ACS patients d...
<p>A: Circulating endothelial cells (CECs), B: Microparticles (MPs), C: Endogen thrombin generation ...
<p>Box plot for plasma levels of VEGF, EGF and MCP-1 in controls and patients at baseline (T0), afte...
<p>Peak thrombin (A) and endogenous thrombin potential (B) were measured post-filtration (light grey...
BACKGROUND: Increased thrombin generation is asso-ciated with an increased risk of recurrent venous ...
<p>Baseline characteristics according to eGFR categories based on the last serum creatinine levels d...
Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concent...
<p>Dashed line indicates end of hemorrhage and beginning of reperfusion period. Data is depicted as ...
<p><b>Biomarkers:</b> N, sustained normalization of values throughout follow-up; nsn: non-sustained ...
<p>Abbreviations: IN<sub>0</sub>: tinzaparin injection before the start of the session at the inlet ...
<p>Median hemoglobin (A) and platelet counts (B) at baseline, at week 4, 8 and 12 and the nadir hemo...
<p>Plasma levels of TIMPs, CRP and I-FABP during follow-up of 3 patient groups.</p
<p>Percentage of patients with at least one dose reduction of RBV or PegIFN, at least one blood tran...
The serum levels of fucosylated haptoglobin at baseline and the end of treatment.</p
<p>Abbreviations : percentage of reticulocytes (Reti), lactate deshydrogenase (LDH), leukocytes (Leu...
<p>Thrombin generation analysis (1 pM TF) of plasma collected from 104 ACS and 42 non-ACS patients d...
<p>A: Circulating endothelial cells (CECs), B: Microparticles (MPs), C: Endogen thrombin generation ...
<p>Box plot for plasma levels of VEGF, EGF and MCP-1 in controls and patients at baseline (T0), afte...
<p>Peak thrombin (A) and endogenous thrombin potential (B) were measured post-filtration (light grey...
BACKGROUND: Increased thrombin generation is asso-ciated with an increased risk of recurrent venous ...
<p>Baseline characteristics according to eGFR categories based on the last serum creatinine levels d...
Endogenous thrombin potential following hemostatic therapy with 4-factor prothrombin complex concent...
<p>Dashed line indicates end of hemorrhage and beginning of reperfusion period. Data is depicted as ...